Abstract:Multiple myeloma (MM) is an incurable B-cell malignancy. High-dose chemotherapy with stem cell support has achieved higher response rates than conventional therapy, but few patients remain in long-term remission. Arsenic trioxide (As2O3) is an effective treatment for acute promyelocytic leukemia. Current clinical studies are investigating arsenic as a therapeutic agent for malignancies. The mechanism of cytotoxicity inducted by As2O3 has not been known thoroughly. Constitutively activated NF-κB is a characteristic of different tumor entities including MM clones and malignant plasma cells from MM patients. It plays an important role in maintaining tumor cell proliferation and protecting cell from apoptosis. The study was to explore the possible mechanism of As2O3 effects on MM lines. Materials and methods: The human MM cell lines of KM3 and RPMI8226 were provided by Hematology Institution of Zhejiang University. The concentration of As2O3 in cell culture system was from 0.5μmol/L to 20μmol/L, 24 hours was selected as the termination point of cell culture. Cell culture without As2O3 and first-antibody-dismissed test were enrolled as controls. Both of the MM lines were treated with As2O3 in various concentrations. The restrained proliferation was observed by drawing growth curve. MTT bioassay was used to examine the effect of As2O3 on cell growth and the concentration of 50% growth inhibition( IC50) calculated respectively. Apoptosis and changes of IκB-α protein was observed by flow cytometry(FCM). Changes and subcellular localization of IκB-α protein were observed by fluorescence microscopy. Western blot was also used to analyze the expression of NF-κB in nuclear. Results: As2O3 inhibited the proliferation of both MM lines, and IC50 of KM3 and RPMI8226 was 9.61μmol/L and 8.01μmol/L respectively. After exposure to As2O3, both of the lines were induced to apoptosis. With As2O3 concentration varied from 0.5μmol/L to 20μmol/L the apoptosis rate of KM3 and RPMI8226 was concentration-dependent measured by FCM. After 24 hours treated with 20μmol/L As2O3, the apoptosis rate of KM3 cells was 41.18% while that of RPMI8226 was 65.25%. It seemed that RPMI8226 cell was more sensitive to As2O3. FCM analysis showed a significant increase in the percentage of G2/M phase cells, from 13.74% to 41.72%, and a decrease percentage of S phase cells from 35.11% to 23.96%. The level of IκB-α in cytoplasm was down-regulated after As2O3 stimulation in both cell lines. The down-regulation of IκB-α from 79.68% to 51.57% was confirmed by FCM in KM3 treated with 10μmol/L As2O3 (p<0.01), the effect was concentration-dependent. While the IκB-α in RPMI8226 changed from 79.72% to 34.08% (p<0.01). Immunofluorescence assay showed that IκB-α localized in cytoplasm mostly. The level of IκB-α protein was down-regulated after As2O3 stimulation. The results showed that KM3 and RPMI8226 lines expressed constitutively activity NF-κB and As2O3 down-regulated the constitutive expression of NF-κB in both cell lines but with different kinetics. Conclusions: As2O3 could not only inhibit the proliferation but also induce apoptosis of KM3 and RPMI8226 cells. The mechanisms of its effect on MM cells may include decreasing the constitutive activity of NF-κB, subsequently down-regulating the expression of various gene products controlled by NF-κB, thus inducing apoptosis in MM cells. As2O3 could inhibit the proliferation of MM cells by changing MM cell cycle and inducing G2/M phase arrest.

[Experimental Research on the Mechanisms of Human Multiple Myeloma LP-1 Cell Apoptosis Induced by Oridonin].

Altered Gene Expression Reveals Molecular Mechanisms Underlying Oridonin-Induced Apoptosis of Multiple Myeloma LP-1 Cells

Oridonin Inhibits Bxpc-3 Cell Growth Through Cell Apoptosis

Proteomic Analysis of Oridonin-Induced Apoptosis in Multiple Myeloma Cells

Mechanism Of Arsenic Trioxide-Induced Apoptosis On Multiple Myeloma Cells.

Inhibitory Effect of Oridonin on Proliferation of RPMI8226 Cells and the Possible Underlying Mechanism

Induction of Apoptosis and G2/M Cell Cycle Arrest by Oridonin on Human Pancreatic Cancer PANC-1 Cells

Mechanisms of oxaliplatin-induced apoptosis of human multiple myeloma cell RPMI8226]

Study on Cyclin D/Rb/p16 Signal Pathway of BxPC-3 Cell Line Treated with Oridonin

Oridonin triggers apoptosis in colorectal carcinoma cells and suppression of microRNA-32 expression augments oridonin-mediated apoptotic effects

Influence of Oridonin Combined with Melphalan on Proliferation and Apoptosis of Human Myeloma RPMI8226 Cells

Study Of Autocrine M-Protein Of Lp-1 Cells Antagonist As2o3-Mediated Programmed Cell Death

Oridonin Induces Apoptosis of Laryngeal Carcinoma Via Endoplasmic Reticulum Stress

Induction of Apoptosis and G2/M Cell Cycle Arrest by Oridonin in Human Gastric Cancer BGC-823 Cells

Study on the mechanism for oridonin-induced apoptosis of human colon cancer cells

Reactive oxygen species mediate oridonin-induced apoptosis through DNA damage response and activation of JNK pathway in diffuse large B cell lymphoma

Oridonin Induces G2/M Cell Cycle Arrest and Apoptosis Via the PI3K/Akt Signaling Pathway in Hormone-Independent Prostate Cancer Cells.

Apoptosis Induction of Human Gastric Cancer SGC-7901 Cells by Oridonin and Its Mechanism

Oridonin induces human epidermoid carcinoma A431 cell apoptosis through tyrosine kinase and mitochondrial pathway.

Polyphyllin I Induces Cell Cycle Arrest and Apoptosis in Human Myeloma Cells Via Modulating Β‐catenin Signaling Pathway

[Effect of Mitoxantrone on Proliferation and Apoptosis of Human Multiple Myeloma Cell RPMI8226].